Abstract
Introduction. Antimicrobials are essential for maintaining animal health; however, their use exerts selective pressure that promotes antimicrobial resistance. Therefore, monitoring antimicrobial use (AMU) is critical for managing the emergence and selection of resistance and various metrics have been developed in veterinary medicine to monitor these usage patterns.
Gap statement. Although metrics such as sales volume are widely used, they do not account for differences in antimicrobial potency. Currently, no defined daily dose metric specific to food-producing animals in Korea has been established to accurately assess domestic usage patterns.
Aim. In this study, we aimed to establish defined daily doses for Republic of Korea (DDDkr) for antimicrobial agents approved for use in cattle, pigs and poultry and to compare these values with the defined daily doses for animals (DDDvet) established by the European Medicines Agency (EMA).
Methodology. A total of 931 veterinary antimicrobial products approved and marketed with recorded sales volumes for food-producing animals in the Republic of Korea as of 2023 were analysed. DDDkr were defined following EMA principles, based on species, administration route and antimicrobial agents. To quantitatively compare the derived DDDkr values with existing DDDvet standards, the quotient of daily defined doses (QDDD) was calculated.
Results. We established 200 DDDkr values: 80 for cattle, 80 for pigs and 40 for poultry. Existing DDDvet values covered 57.5% of Korean veterinary antimicrobials, as certain formulations (sprays, intramammary and intrauterine products) lacked comparable EMA values. Median QDDD values were 0.87 for cattle, 0.79 for pigs and 0.75 for poultry, reflecting significant differences between DDDkr and DDDvet for cattle and pigs (P<0.05), whereas no significant difference was observed in poultry. Comparative analysis showed that most QDDD values were less than 1.
Conclusion. This study is the first to establish a DDDkr for food-producing animals in Korea. The results indicate that national dosages are generally lower than those defined in European standards, highlighting the need for country-specific metrics such as DDDkr to ensure more accurate domestic AMU monitoring.
Keywords: antimicrobial use (AMU), defined daily doses, defined daily doses for animals (DDDvet), defined daily doses for Republic of Korea (DDDkr), quotient of daily defined doses (QDDD)
Introduction
Antimicrobials are essential medicinal products used in food-producing animals to ensure animal health and welfare by treating, controlling and preventing infectious diseases [1, 2]. However, widespread administration of these agents exerts selective pressure that favours the emergence and spread of antimicrobial-resistant bacteria, which poses a significant threat to global public health [3, 4]. Recognizing this risk, international organizations and national governments have prioritized the optimization and reduction of antimicrobial use (AMU) [2, 5–11]. Accurate measurement and continuous monitoring of AMU are essential for the design, implementation and evaluation of effective antimicrobial stewardship strategies and resistance mitigation policies [6, 12]. To achieve this, establishing robust surveillance systems based on standardized and comparable quantitative metrics is crucial. Consequently, various metrics and data collection methods are currently employed by different national and international surveillance systems to monitor AMU trends [12–15].
Among the diverse AMU indicators used globally, weight- and dose-based metrics are the most prominent [5, 6, 12]. Weight-based indicators include the total mass of active substances, milligram per population correction unit employed by the European Medicines Agency (EMA) [6], and milligram per kilogram of animal biomass adopted by the World Organisation for Animal Health [5]. In contrast, dose-based metrics include the prescribed daily doses and the used daily doses, which measure the intended prescription and the actual amount administered at the farm level, respectively [6, 15, 16]. However, these metrics present distinct limitations for national-level surveillance. Although weight-based metrics facilitate broad international comparisons, they do not account for variations in antimicrobial potency and formulation, thereby failing to capture the true intensity of therapeutic exposure [6, 13, 16, 17]. Conversely, although dose-based metrics offer the highest accuracy, the labour-intensive and complex nature of collecting granular prescriptions and use data makes their application significantly challenging on a national scale [6, 16].
To bridge the gap between practical data collection and precise usage estimation, the EMA adopted the concept of the defined daily doses (DDD) from human medicine for veterinary practice, formally establishing defined daily doses for animals (DDDvet) in 2016 [18–20]. DDDvet is defined as the assumed average maintenance dose per kilogram of animal body weight per day for a specific species and serves as a crucial standardized technical unit [18, 20]. Unlike weight-based metrics, DDDvet inherently corrects for variations in pharmacological potency and administration routes, allowing for a more accurate reflection of therapeutic intensity [18, 20]. However, due to discrepancies in recommended doses specified in product-specific summaries of product characteristics, establishing standardized daily doses at the active-substance level requires critical compromises, such as adopting a median, mean or maximum value [21]. Consequently, discrepancies between these standardized values and actual doses used can lead to either an underestimation or overestimation of total antimicrobial consumption, presenting a notable drawback of this approach [21]. Furthermore, it enables the estimation of population-level antimicrobial exposure using readily accessible aggregated national sales data, eliminating the need for labour-intensive farm-level records [18, 22].
Currently, South Korea is reporting weight-based sales data; however, no DDD metric specific to domestic food-producing animals has been established. In this study, we aimed to develop defined daily doses for the Republic of Korea (DDDkr) for approved and marketed single or combination veterinary antimicrobial active substances, serving as a standardized metric for national surveillance, and to compare these values with the EMA’s DDDvet values.
Methods
Defined daily doses in Korea
DDDkr values were established at the active substance level following the principles of the EMA, with modifications to align with the domestic context [18]. As of 2023, data on veterinary antimicrobial products approved and commercially available for use in cattle, pigs and poultry in the Republic of Korea was obtained from the Korea Animal Health Products Association. For each product, information regarding the recommended daily dosage, recommended treatment duration and approved indications was collected directly from the product labels.
The baseline calculations for these values were determined by the target species, route of administration and whether the formulation was a single-ingredient or combination-ingredient product. If two or more commercially available products contained the same active substance, the final DDD value was calculated as the arithmetic mean of their recommended daily dosages. For products with varying dosages across different indications, the arithmetic mean of the indication-specific doses was applied. In cases where the dosage varied over the treatment period (such as a different dose for the first few days), a time-weighted average was calculated across the entire recommended treatment duration. For combination-ingredient antimicrobials, DDD values were assigned separately to each active substance according to the EMA guidelines, considering the synergy of antimicrobial combinations.
Specific calculation methodologies were applied based on the administration route. For formulations administered through feed or water, dosages were converted to milligram per kilogram of body weight using standard conversion rates published by the EMA [18]. For intramammary and intrauterine products, daily doses in mg kg−1 day−1 were calculated by dividing the total antimicrobial dose by a standard cattle body weight of 635 kg, in accordance with the Japanese methodology [22], and further adjusting this value by the application period (either an assumed 4 days or the specific duration recommended on the product label). For spray formulations, DDDkr values were determined based on the daily dosage (mg kg−1 body weight day−1) specified on the approved product labels in the Republic of Korea.
Quotient of Korean and European values (QDDD)
The quotient of daily defined doses (QDDD) was calculated by comparing the DDD values in Korea and Europe [20] as follows:
A QDDD of 1 indicates identical dosages between the two systems, whereas values greater or less than 1 indicate higher or lower Korean dosages, respectively. A comparative analysis was performed only when the corresponding DDDvet values were available. The EMA values for the antimicrobials were excluded from comparison when unavailable. Intramammary and intrauterine products were not compared because DDDvet was not available in mg kg−1 day−1.
Statistical analysis
Statistical analysis was performed to evaluate differences between the established DDDkr and European DDDvet values using R Statistical Software (version 4.4.2, R Foundation for Statistical Computing, Vienna, Austria). The Wilcoxon signed-rank test was used for paired samples to determine the statistical significance of the differences between the two metrics. A P-value≤0.05 was considered statistically significant.
Results
Analysis of veterinary antimicrobials for food-producing animals in Korea
A total of 931 antimicrobial products comprising 53 active substances commercially available for food-producing animals in the Republic of Korea as of 2023 were analysed (Table 1, Data S1–S3, available in the online Supplementary Material). Most of these products were approved for pigs (n=842), followed by cattle (n=431) and poultry (n=384). Oral formulations were predominant, accounting for 68.6% (n=639) of all products, whereas injectable formulations accounted for 27.8% (n=259). Other formulations included intramammary (n=22), topical (n=9) and intrauterine (n=2) products (Table 1). Florfenicol was the most frequently approved active substance (n=133), followed by amoxicillin (n=85) and tiamulin (n=75) (Data S1–S3). Based on these product profiles, 200 DDDkr values were established, including 103 values for oral administration, 72 for injection, 18 for intramammary administration, 5 for topical administration and 2 for intrauterine administration (Table 2, Data S1–S3).
Table 1. Number of antimicrobial products for cattle, pigs and poultry in Korea by administration route and number of active substances contained.
| Animal | Product type | Administration route | Total | ||||
|---|---|---|---|---|---|---|---|
| Oral | Injection | Intramammary | Intrauterine | Spray | |||
| Cattle | Single | 150 | 193 | 11 | 2 | 0 | 356 |
| Combination | 26 | 36 | 11 | 0 | 2 | 75 | |
| Sub-total (%) |
176 (40.8) |
229 (53.1) |
22 (5.1) |
2 (0.5) |
2 (0.5) |
431 (100) |
|
| Pig | Single | 462 | 202 | 0 | 0 | 7 | 671 |
| Combination | 129 | 40 | 0 | 0 | 2 | 171 | |
| Sub-total (%) |
591 (70.2) |
242 (28.7) |
0 (0) |
0 (0) |
9 (1.1) |
842 (100) |
|
| Poultry | Single | 295 | 9 | 0 | 0 | 0 | 304 |
| Combination | 77 | 3 | 0 | 0 | 0 | 80 | |
| Sub-total (%) |
372 (96.9) |
12 (3.1) |
0 (0) |
0 (0) |
0 (0) |
384 (100) |
|
| Total | Single | 500 | 213 | 11 | 2 | 7 | 733 |
| Combination | 139 | 46 | 11 | 0 | 2 | 198 | |
| Total (%) |
639 (68.6) |
259 (27.8) |
22 (2.4) |
2 (0.2) |
9 (1.0) |
931 (100) | |
Table 2. Number of established DDDkr values for cattle, pigs and poultry in Korea by administration route and number of active substances contained.
| Product type | Animal | Administration route | Total | ||||
|---|---|---|---|---|---|---|---|
| Oral | Injection | Intramammary | Intrauterine | Spray | |||
| Single | Cattle | 8 | 17 | 7 | 2 | 0 | 34 |
| Pig | 22 | 17 | 0 | 0 | 1 | 40 | |
| Poultry | 18 | 3 | 0 | 0 | 0 | 21 | |
| Sub-total (%) | 48 (50.5) |
37 (38.9) |
7 (7.4) |
2 (2.1) |
1 (1.1) |
95 (100) |
|
| Combination | Cattle | 15 | 18 | 11 | 0 | 2 | 46 |
| Pig | 23 | 15 | 0 | 0 | 2 | 40 | |
| Poultry | 17 | 2 | 0 | 0 | 0 | 19 | |
| Sub-total (%) | 55 (52.4) |
35 (33.3) |
11 (10.5) |
0 (0) |
4 (3.8) |
105 (100) |
|
| Sub-total (%) | 103 (51.5) |
72 (36) |
18 (9) |
2 (1) |
5 (2.5) |
200 (100) |
|
Comparison of DDDkr with European DDDvet for antimicrobial agents in cattle
A total of 80 DDDkr values were defined for 45 antimicrobial agents for cattle (Table 2, Data S1). The route of administration with the most assigned DDDkr was injection, which was defined in 35 cases. This was followed by oral, intramammary, intrauterine and topical administration. Examination of the daily dose distribution revealed a wide range of doses (Table 3, Data S1). The highest-selling antimicrobial agent [23], amoxicillin, was defined as 7.1 mg kg−1 in single oral administration, 5.7 mg kg−1 in combination oral administration and 13.1 mg kg−1 in single injection administration. The antimicrobial agent with the largest inter-product variation in recommended doses was spiramycin, which ranged from 3 to 50 mg kg−1 and differed by 1,667% (Data S1). Sixty-nine percent of DDDkr values for cattle had the same mean and median values (Data S1). A detailed list of DDDkr values is provided in Data S1.
Table 3. Comparison of DDDkr and DDDvet values for major antimicrobial agents used in cattle.
| Class | Antimicrobial agent | Administration route | Product type | Count | DDDkr | Median | Minimum | Maximum | DDDkr | DDDvet | QDDD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aminoglycosides | Neomycin | Oral | Single | 2 | 8.9 | 8.9 | 7.7 | 10.0 | 17.7 | 21 | 0.42 |
| Combination | 3 | 2.4 | 2.6 | 2.0 | 2.6 | 8.4 | – | – | |||
| Injection | Combination | 1 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.4 | 1.01 | ||
| Intramammary | Combination | 8 | 0.8 | 0.6 | 0.4 | 1.9 | 2.1 | – | – | ||
| Amphenicols | Florfenicol | Injection | Single | 16 | 18.8 | 20.0 | 10.0 | 20.0 | 42.2 | 13 | 1.44 |
| Cephalosporins | Ceftiofur | Injection | Single | 40 | 1.0 | 1.0 | 1.0 | 1.0 | 3.0 | 1 | 1.00 |
| Intramammary | Combination | 1 | 0.6 | 0.6 | 0.6 | 0.6 | 2.5 | – | – | ||
| Macrolides | Tylosin | Oral | Single | 18 | 0.2 | 0.2 | 0.2 | 0.2 | 4.2 | 41 | 0.005 |
| Injection | Single | 5 | 8.6 | 7.0 | 7.0 | 15.0 | 22.4 | 13 | 0.66 | ||
| Combination | 3 | 4.9 | 5.0 | 2.6 | 7.0 | 11.3 | – | – | |||
| Penicillins | Amoxicillin | Oral | Single | 48 | 7.1 | 7.5 | 6.5 | 9.8 | 31.2 | 20 | 0.35 |
| Combination | 3 | 5.7 | 3.3 | 3.3 | 10.5 | 22.7 | – | – | |||
| Injection | Single | 15 | 13.1 | 15.0 | 7.0 | 15.0 | 23.6 | 8.3 | 1.58 | ||
| Ampicillin | Oral | Single | 44 | 9.5 | 9.5 | 9.5 | 9.5 | 47.3 | 29 | 0.33 | |
| Combination | 14 | 5.0 | 5.0 | 5.0 | 5.0 | 25.0 | – | – | |||
| Injection | Single | 11 | 7.8 | 7.5 | 7.5 | 11.3 | 10.3 | 11 | 0.71 | ||
| Combination | 1 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | – | – | |||
| Intramammary | Combination | 1 | 0.4 | 0.4 | 0.4 | 0.4 | 1.6 | – | – | ||
| Penicillin | Injection | Single | 4 | 5.2 | 4.0 | 3.6 | 9.0 | 11.6 | 14 | 0.37 | |
| Combination | 19 | 5.8 | 5.6 | 1.8 | 13.5 | 16.7 | 2.9 | 1.99 | |||
| Intramammary | Combination | 1 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | – | – | ||
| Polypeptides | Colistin | Oral | Single | 27 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 4.8 | 0.09 |
| Combination | 17 | 0.3 | 0.2 | 0.2 | 0.6 | 1.5 | – | – | |||
| Injection | Combination | 3 | 1.4 | 1.2 | 1.2 | 1.8 | 2.4 | 2.6 | 0.55 | ||
| Quinolones | Enrofloxacin | Oral | Single | 1 | 3.8 | 3.8 | 3.8 | 3.8 | 15.0 | 4.7 | 0.80 |
| Injection | Single | 31 | 4.5 | 4.2 | 3.8 | 7.5 | 16.5 | 4.2 | 1.07 | ||
| Intramammary | Single | 1 | 2.5 | 2.5 | 2.5 | 2.5 | 7.6 | – | – | ||
| Tetracyclines | Oxytetracycline | Oral | Single | 9 | 22.0 | 22.0 | 21.6 | 22.2 | 230.8 | 20 | 1.10 |
| Combination | 2 | 26.0 | 26.0 | 26.0 | 26.0 | 104.0 | – | – | |||
| Injection | Single | 5 | 15.5 | 20.0 | 8.8 | 20.0 | 15.5 | 6.5 | 2.39 |
The comparison between DDDkr and DDDvet in cattle involved the analysis of 41 pairs (51%) of oral and injectable antimicrobial values. Intramammary and intrauterine antimicrobials were excluded from the comparison because of differences in calculation methods. More than half of the DDDkr values (61%) were lower than the DDDvet values, whereas only 32% were higher. Notably, a difference of over 50% was observed in 15 comparison values (37%) (Fig. 1a and S1). Among the commonly used antimicrobial agents for Korean cattle, the DDDkr for oral amoxicillin (QDDD=0.35), oral ampicillin (QDDD=0.33), injectable ampicillin (QDDD=0.71), tylosin (QDDD=0.005) and injectable tylosin (QDDD=0.66) were all lower than the EMA values. However, the DDDkr value for injectable amoxicillin (QDDD=1.58) was higher than that for DDDvet (Table 3). The DDDkr values for cattle differed significantly from the DDDvet values (P=0.0388), with a median QDDD of 0.87.
Fig. 1. Comparison of the DDDkr of antimicrobial agents approved for use in food-producing animals with the corresponding values of the EMA (DDDvet). (a) Cattle; (b) pigs; and (c) poultry.

Comparison of DDDkr with European DDDvet for antimicrobial agents in pigs
A total of 80 DDDkr values were defined for 43 antimicrobial agents for pigs (Table 2, Data S2). The most common DDDkr route of administration was oral, with 45 defined values, followed by injectable administration and topical formulations. The investigation of the distribution of daily dosages revealed a wide range of dosages (Table 4). The highest-selling antimicrobial agent [23], florfenicol, was defined as 5.8 mg kg−1 in single oral administration, 14.1 mg kg−1 in single injection administration and 8 mg kg−1 in combination injection administration. The antimicrobial with the largest variation in recommended dosages among the products was oral florfenicol, with a range of 1.2–10 mg kg−1, differing by 833% (Table 3, Data S2). Forty-nine percent of DDDkr values for pigs had the same mean and median values (Data S2). A detailed list of DDDkr values was provided in Data S2.
Table 4. Comparison of DDDkr and DDDvet values for major antimicrobial agents used in pigs.
| Class | Antimicrobial agent | Administration route | Product type | Count | DDDkr | Median | Minimum | Maximum | DDDkr | DDDvet | QDDD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphenicols | Florfenicol | Oral | Single | 107 | 5.8 | 10.0 | 1.2 | 10.0 | 34.7 | 10 | 0.58 |
| Injection | Single | 16 | 14.1 | 15.0 | 7.5 | 15.0 | 31.6 | – | – | ||
| Combination | 5 | 8.0 | 10.0 | 5.0 | 10.0 | 19.2 | 9.5 | 0.84 | |||
| Macrolides | Tilmicosin | Oral | Single | 54 | 16.9 | 20.0 | 10.0 | 20.0 | 184.1 | 15 | 1.12 |
| Tylosin | Oral | Single | 32 | 10.8 | 4.4 | 4.4 | 25.0 | 172.9 | 12 | 0.90 | |
| Combination | 13 | 4.4 | 4.4 | 4.4 | 4.4 | 92.4 | – | – | |||
| Injection | Single | 5 | 6.2 | 6.0 | 6.0 | 7.0 | 16.1 | 13 | 0.48 | ||
| Combination | 10 | 3.4 | 2.5 | 2.2 | 6.0 | 8.1 | – | – | |||
| Penicillins | Amoxicillin | Oral | Single | 64 | 7.6 | 7.5 | 6.5 | 20.0 | 34.6 | 17 | 0.45 |
| Combination | 4 | 5.1 | 3.3 | 3.3 | 10.5 | 20.3 | – | – | |||
| Injection | Single | 16 | 12.9 | 15.0 | 7.0 | 15.0 | 24.3 | 8.9 | 1.45 | ||
| Ampicillin | Oral | Single | 44 | 12.5 | 12.5 | 12.5 | 12.5 | 62.2 | 30 | 0.42 | |
| Combination | 14 | 5.0 | 5.0 | 5.0 | 5.0 | 25.0 | – | – | |||
| Injection | Single | 11 | 7.8 | 7.5 | 7.5 | 11.3 | 10.3 | 12 | 0.65 | ||
| Combination | 1 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | – | – | |||
| Polypeptides | Bacitracin | Oral | Single | 17 | 7.2 | 4.0 | 4.0 | 14.0 | 18.2 | – | – |
| Pleuromutilins | Tiamulin | Oral | Single | 49 | 7.7 | 6.2 | 3.2 | 12.2 | 62.1 | 9.7 | 0.80 |
| Combination | 24 | 3.2 | 3.3 | 0.9 | 4.0 | 19.9 | – | – | |||
| Injection | Single | 2 | 12.5 | 12.5 | 12.5 | 12.5 | 40.6 | 12 | 1.04 | ||
| Sulfanamides | Sulfamethazine | Oral | Combination | 18 | 4.9 | 4.4 | 4.4 | 8.8 | 90.7 | – | – |
| Sulfamethoxazole | Oral | Combination | 29 | 14.7 | 18.0 | 4.0 | 26.7 | 68.0 | 20 | 0.74 | |
| Injection | Combination | 2 | 9.9 | 9.9 | 6.5 | 13.3 | 29.8 | 20 | 0.50 | ||
| Tetracyclines | Chlortetracycline | Oral | Single | 13 | 11.4 | 8.8 | 6.0 | 22.0 | 115.9 | 31 | 0.37 |
| Combination | 24 | 9.2 | 9.9 | 4.0 | 10.0 | 62.4 | – | – |
The comparison of DDDkr and DDDvet in pigs involved the evaluation of 52 pairs (65%) of oral and injectable antimicrobials. More than half the DDDkr values (69%) were lower than the DDDvet values, whereas 29% were higher. Notably, a difference of more than 50% was observed in 16 comparison values (31%) (Figs 1b and S2). Among the commonly used antimicrobials in Korean pigs, the DDDkr for oral amoxicillin (QDDD=0.45), oral florfenicol (QDDD=0.58), injectable florfenicol (QDDD=0.84), oral tylosin (QDDD=0.9) and injectable tylosin (QDDD=0.48) were lower than the EMA values. In contrast, the daily dose of injectable amoxicillin (QDDD=1.45) was higher than the EMA values (Table 4). A significant difference was observed between DDDkr and DDDvet in pigs (P=0.000678), with a median QDDD of 0.79.
Comparison of DDDkr with European DDDvet for antimicrobial agents in poultry
A total of 40 DDDkr values were defined for 29 antimicrobial agents for poultry (Table 2, Data S3). The commonly assigned DDDkr route of administration was oral, with 35 defined values, followed by injectable administration. An investigation of the distribution of daily dosages revealed a wide range of dosages (Table 5). Florfenicol, the highest-selling antimicrobial agent [23], was defined as 20 mg kg−1 in single oral administration. Oral spectinomycin exhibited the largest variation in recommended dosages among products, with a range of 8.6–76.8 mg kg−1 and differing by 895% (Data S3). Sixty-three percent of DDDkr values for poultry had the same mean and median values. A detailed list of DDDkr values was provided in Data S3.
Table 5. Comparison of DDDkr and DDDvet values for major antimicrobial agents used in poultry.
| Class | Antimicrobial agent | Administration route | Product type | Count | DDDkr | Median | Minimum | Maximum | DDDkr | DDDvet | QDDD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphenicol | Florfenicol | Oral | Single | 56 | 20.0 | 20.0 | 20.0 | 20.0 | 100.7 | 30 | 0.67 |
| Lincosamide | Lincomycin | Oral | Single | 9 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 8.6 | 0.05 |
| Combination | 23 | 15.2 | 11.4 | 8.6 | 38.3 | 241.3 | 22 | 0.69 | |||
| Injection | Combination | 3 | 21.7 | 10.0 | 10.0 | 45.0 | 65.0 | – | – | ||
| Macrolide | Tiamulin | Oral | Single | 26 | 38.8 | 43.1 | 10.4 | 43.1 | 161.2 | 23 | 1.69 |
| Combination | 9 | 9.3 | 8.6 | 8.6 | 15.2 | 51.7 | – | – | |||
| Injection | Single | 1 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | – | – | ||
| Tilmicosin | Oral | Single | 34 | 17.0 | 17.3 | 15.5 | 17.3 | 68.2 | 18 | 0.95 | |
| Penicillin | Amoxicillin | Oral | Single | 26 | 30.0 | 30.0 | 15.0 | 45.0 | 141.9 | 16 | 1.88 |
| Combination | 1 | 33.0 | 33.0 | 33.0 | 33.0 | 132.0 | – | – | |||
| Ampicillin | Oral | Single | 44 | 15.1 | 15.0 | 15.0 | 20.0 | 75.2 | 108 | 0.14 | |
| Combination | 14 | 11.5 | 11.5 | 11.5 | 11.5 | 57.5 | – | – | |||
| Polypeptide | Bacitracin | Oral | Single | 20 | 8.6 | 6.3 | 3.9 | 21.5 | 25.7 | – | – |
| Colistin | Oral | Single | 17 | 1.1 | 0.7 | 0.7 | 2.4 | 2.1 | 5.1 | 0.21 | |
| Combination | 20 | 3.1 | 1.6 | 1.4 | 9.0 | 15.2 | – | – | |||
| Sulfanamide | Sulfamethoxazole | Oral | Combination | 16 | 28.5 | 26.0 | 15.5 | 46.0 | 146.0 | 27 | 1.06 |
| Tetracycline | Chlortetracycline | Oral | Single | 14 | 32.0 | 33.6 | 13.2 | 50.1 | 208.0 | 30 | 1.07 |
| Combination | 10 | 25.9 | 25.9 | 25.7 | 26.0 | 134.5 | – | – |
The comparison of DDDkr and DDDvet in poultry involved the evaluation of 22 pairs (55%) of oral antimicrobials. More than half of the DDDkr values (68%) were lower than the DDDvet values, whereas only 32% were higher. Notably, a difference of more than 50% was observed in seven comparison values (32%) (Figs 1c and S3). Among the commonly used antimicrobials for Korean poultry, the DDDkr values for florfenicol (QDDD=0.67) and ampicillin (QDDD=0.14) were lower than the EMA values for daily dosages. In contrast, the DDDkr for chlortetracycline (QDDD=1.07) was used at a similar daily dosage (Table 5). For poultry, the difference between DDDkr and DDDvet showed a numerical trend but was not statistically significant (P=0.0715), with a median QDDD of 0.75.
Discussion
As the use of antimicrobials exerts selective pressure that favours the emergence of resistance, various standardized metrics and data collection methods are currently used by national and international surveillance systems to monitor usage trends and mitigate these risks [1–15]. In this study, DDDkr standards were developed for cattle, pigs and poultry for the first time for approved products containing complex antimicrobial active ingredients used in Korea, and DDDkr was compared with the DDDvet of the EMA.
The number of established DDDkr values for pigs and cattle in our study was 80 each, and the number of approved products for pigs was significantly higher than that for cattle. In addition, Japan had a similar pattern, where the number of antimicrobial products used for pigs was higher than that for cattle [22]. These numerical differences may be attributable to the high redundancy of products containing the same active ingredients within the pig industry because the market structure relies heavily on the availability of generic off-patent antimicrobials rather than the introduction of new treatment options [5, 6, 22]. In this study, we found that the ratio of administration routes differed depending on the livestock species. Pigs and poultry had high oral administration rates, whereas cattle had a high injection rate. Consistent with our findings, global trends indicate that oral products are predominantly used in pigs and poultry, whereas injectable products are prevalent in cattle [16, 22, 24, 25]. The differences in these species-specific administration routes are attributable to the unique management systems and physiological characteristics of each species [26, 27]. In the pig and poultry sectors, oral group drug treatment is preferred because of labour efficiency and the mass-rearing environment [26, 27]. Conversely, the high dependence on the injection route for cattle may be due to the feasibility of individual animal management and the clinical need to avoid disturbances in rumen microbial populations that may arise from oral administration [27].
In the present study, the DDDkr values were generally lower than those of the European EMA references (DDDvet) across all three animal species, with median QDDD values of 0.87 for cattle, 0.79 for pigs and 0.75 for poultry. This consistent trend of lower national dosages aligned with findings from other non-European countries, such as Japan (median QDDD: cattle 0.66, pigs 0.61) and Canada [16, 22]. In contrast, a study in European context like Switzerland reported QDDD values closer to 1.0 (median 0.91), indicating relatively minor deviations from EMA standards [28]. Further specific QDDD analysis revealed that 75% of the oral antimicrobials and 54% of the injectable antimicrobials had values less than 1. Low QDDD values were observed for oral tylosin in cattle, injectable sulfadimethoxine in pigs, and oral lincomycin in poultry. Conversely, exceptionally high QDDD values were observed for injectable tilmicosin in cattle, injectable oxytetracycline in pigs, and oral amoxicillin in poultry. Similar significant differences for certain agents have been reported in other countries, including Japan [22]. The difference between DDDvet and DDDkr may be attributable to several factors. First, these differences may arise due to variations in labelling regulations, treatment indications and husbandry practices across countries [16, 22]. For instance, regarding labelling regulations and husbandry practices, European product labels generally authorize individual medication via milk for calves, whereas Korean labels frequently approve group medication via feed, which may lead to a lower authorized dosage per kilogram of body weight [29, 30]. Second, the EMA’s DDDvet was derived from the average of the assigned dosages across nine EU member states. As authorized dosages for the same antimicrobial agent can vary significantly among nations, the inclusion of countries with higher approved dosages can distort upward the overall average, resulting in a higher baseline than the national criteria of a single country, such as Korea [18, 20]. For example, a previous European multi-country study documented that national product authorizations for swine antimicrobials vary among countries, with Germany approving significantly higher authorized daily dosages for key agents – such as amoxicillin, chlortetracycline and tiamulin – than nations like France, Belgium and Sweden [31]. Finally, the observed discrepancies could be attributed to outdated dosages [22]. In Australia, outdated antimicrobial labelling in horses and cattle was reported to lead to underdosing [32, 33]. In Japan, it was suggested that manufacturers preferred registering products with previously approved dosages rather than new ones to reduce time and cost burdens, hindering label updates to clinically effective dosages [22]. Similarly in Korea, seeking product approvals based on existing dosages rather than introducing revised dosing regimens remained a standard commercial practice, thereby perpetuating the use of historical label values. Determining all the factors that account for these discrepancies between DDDkr and DDDvet, however, was outside the boundaries of this study. Given that underdosing could accelerate the selection of resistant pathogens, these older products approved at very low doses might warrant systematic re-evaluation to align with modern antimicrobial stewardship guidelines. Given these fundamental discrepancies, the establishment of DDDkr provides a more appropriate baseline for national surveillance than DDDvet by capturing the current status of veterinary AMU in Korea more accurately. Country-specific metrics like DDDkr, however, may face limitations in direct cross-country evaluations due to methodological differences and product variations. These constraints simply highlight the complementary need for standardized global DDD values to facilitate broader international comparisons [16, 22].
In conclusion, DDDkr values were established by analysing veterinary antimicrobial products approved for use in cattle, pigs and poultry in Korea. The current DDDvet values do not cover all veterinary antimicrobials used in Korea, and a comparison of the defined DDDkr with the European DDDvet showed overall low QDDD values. The absence of DDDvet values for certain antimicrobial agents, combined with these results, suggests that DDDkr is a more suitable metric for accurately reflecting AMU in the Korean livestock industry. Given the methodological differences and differences in approved antimicrobial agents, it is necessary for each country to develop country-specific metrics, such as DDDkr, for effective and precise national AMU monitoring.
Supplementary material
Acknowledgements
We are grateful to the Korea Animal Health Products Association for their valuable data support. English language editing was provided by Editage.
Abbreviations
- AMU
antimicrobial use
- DDD
defined daily dose
- DDDkr
defined daily doses for the Republic of Korea
- DDDvet
defined daily doses for animals
- EMA
European Medicines Agency
- QDDD
quotient of daily defined doses
Footnotes
Funding: The authors declare that they received financial support for the research, authorship and publication of this article. This research was funded by grants from the Animal and Plant Quarantine Agency (N-1543081-2025-29-1), Gimcheon, Republic of Korea.
Author contributions: Conceptualization [S.H.K. and H.M.K.]; Data curation [S.H.K. and J.Y.Y.]; Formal analysis [S.H.K., J.Y.Y. and H.M.K.]; Funding acquisition [Y.S.C.]; Investigation [S.H.K., J.Y.Y. and H.J.K.]; Methodology [S.H.K., J.Y.Y. and H.M.K.]; Project administration [J.Y.Y.]; Supervision [S.K.L., Y.S.C. and H.M.K.]; Validation [S.K.L., Y.S.C. and H.M.K.]; Writing – original draft [S.H.K. J.Y.Y. and H.M.K.]; Writing – review & editing [S.H.K., J.Y.Y. and H.M.K.]. All authors have read and approved the final version of this manuscript.
Ethical statement: No ethical approval is required.
Contributor Information
Seunghoe Kim, Email: hky0114@naver.com;hky0114@korea.kr.
Ju-yeon You, Email: vet100479@korea.kr.
Hyejeong Kang, Email: hjkang128@korea.kr.
Suk-Kyung Lim, Email: imsk0049@korea.kr.
Yun Sang Cho, Email: choys@korea.kr.
Hyun-Mi Kang, Email: greenkang@korea.kr.
References
- 1.Rushton J, Ferreira JP, Stärk KD. OECD Food, Agriculture and Fisheries Papers. Vol. 68. Paris: OECD Publishing; 2014. Antimicrobial resistance: the use of antimicrobials in the livestock sector. vol. [DOI] [Google Scholar]
- 2.World Health Organization (WHO) World Health Organization; 2015. Global action plan on antimicrobial resistance. [DOI] [PubMed] [Google Scholar]
- 3.Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387:176–187. doi: 10.1016/S0140-6736(15)00473-0. [DOI] [PubMed] [Google Scholar]
- 4.O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016.
- 5.World Organisation for Animal Health (WOAH); 2023. Seventh annual report on antimicrobial agents intended for use in animals. [Google Scholar]
- 6.European Medicines Agency . Publications Office of the European Union; 2023. Sales of veterinary antimicrobial agents in 31 european countries in 2022 - trends from 2010 to 2022, thirteenth ESVAC report. [Google Scholar]
- 7.Centers for Disease Control and Prevention (CDC) Atlanta, GA: U.S. Department of Health and Human Services; 2019. Antibiotic resistance threats in the United States, 2019. [Google Scholar]
- 8.Public Health Agency of Canada; 2024. Canadian integrated program for antimicrobial resistance surveillance (CIPARS) 2022 executive summary: key and integrated findings. [Google Scholar]
- 9.Kolwijck E, NethMap SA. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2022. 2023. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands in 2022/MARAN 2023. [Google Scholar]
- 10.Duarte ASR, Birk T, Sandberg M, Lindegaard M, Sönksen UW, et al. DANMAP 2023: use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in denmark. Research Portal Denmark. 2024 [Google Scholar]
- 11.Courtenay M, Castro-Sanchez E, Fitzpatrick M, Gallagher R, Lim R, et al. Tackling antimicrobial resistance 2019-2024 - The UK’s five-year national action plan. J Hosp Infect. 2019;101:426–427. doi: 10.1016/j.jhin.2019.02.019. [DOI] [PubMed] [Google Scholar]
- 12.Sanders P, Vanderhaeghen W, Fertner M, Fuchs K, Obritzhauser W, et al. Monitoring of farm-level antimicrobial use to guide stewardship: overview of existing systems and analysis of key components and processes. Front Vet Sci. 2020;7:540. doi: 10.3389/fvets.2020.00540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mills HL, Turner A, Morgans L, Massey J, Schubert H, et al. Evaluation of metrics for benchmarking antimicrobial use in the UK dairy industry. Vet Rec. 2018;182:379. doi: 10.1136/vr.104701. [DOI] [PubMed] [Google Scholar]
- 14.Collineau L, Belloc C, Stärk KDC, Hémonic A, Postma M, et al. Guidance on the selection of appropriate indicators for quantification of antimicrobial usage in humans and animals. Zoonoses Public Health. 2017;64:165–184. doi: 10.1111/zph.12298. [DOI] [PubMed] [Google Scholar]
- 15.O’Neill L, Rodrigues da Costa M, Leonard F, Gibbons J, Calderón Díaz JA, et al. Does the use of different indicators to benchmark antimicrobial use affect farm ranking? Front Vet Sci. 2020;7:558793. doi: 10.3389/fvets.2020.558793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bosman AL, Loest D, Carson CA, Agunos A, Collineau L, et al. Developing Canadian defined daily doses for animals: a metric to quantify antimicrobial use. Front Vet Sci. 2019;6:220. doi: 10.3389/fvets.2019.00220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lekagul A, Tangcharoensathien V, Yeung S. The use of antimicrobials in global pig production: a systematic review of methods for quantification. Prev Vet Med. 2018;160:85–98. doi: 10.1016/j.prevetmed.2018.09.016. [DOI] [PubMed] [Google Scholar]
- 18.European Medicines Agency; 2015. Principles on assignment of defined daily dose for animals (DDDvet) and defined course dose for animals (DCDvet) [Google Scholar]
- 19.WHO Collaborating Centre for Drug Statistics Methodology . Norwegian Institute of Public Health; 2018. Guidelines for ATC classification and DDD assignment, 2019. [Google Scholar]
- 20.European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) European Medicines Agency; 2016. Defined daily doses for animals (DDDvet) and defined course doses for animals (DCDvet) [Google Scholar]
- 21.Collineau L, Belloc C, Stärk KDC, Hémonic A, Postma M, et al. Guidance on the selection of appropriate indicators for quantification of antimicrobial usage in humans and animals. Zoonoses Public Health. 2017;64:165–184. doi: 10.1111/zph.12298. [DOI] [PubMed] [Google Scholar]
- 22.Fujimoto K, Kawasaki M, Abe R, Yokoyama T, Haga T, et al. Establishing defined daily doses (DDDs) for antimicrobial agents used in pigs, cattle and poultry in Japan and comparing them with European DDD values. PLoS One. 2021;16:e0245105. doi: 10.1371/journal.pone.0245105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Animal and Plant Quarantine Agency (APQA) Monitoring national antimicrobial agents use and resistance in 2023. 2024 https://www.apqa.go.kr/viewwebQiaCom.do?id=64427&type=54_1ndyjsy
- 24.Tuberquia-López BC, Correa-Valencia NM. Colombian standards for antimicrobial dosing in cattle: establishing defined daily doses and defined course doses. Zoonoses Public Health. 2025;72:735–746. doi: 10.1111/zph.70017. [DOI] [PubMed] [Google Scholar]
- 25.Lekagul A, Tangcharoensathien V, Yeung S. Patterns of antibiotic use in global pig production: a systematic review. Vet Anim Sci. 2019;7:100058. doi: 10.1016/j.vas.2019.100058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis. 2002;34 Suppl 3:S93–S106. doi: 10.1086/340246. [DOI] [PubMed] [Google Scholar]
- 27.Constable PD, Hinchcliff KW, Done SH., editors. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs, and Goats. 11 edn. W.B. Saunders Ltd; 2017. p. 2308. p. [DOI] [Google Scholar]
- 28.Echtermann T, Müntener CR, Torgerson PR, Sidler X, Kümmerlen D. Defining daily doses and total doses for the measurement of antibiotic usage in Swiss pig production. Schweiz Arch Tierheilkd. 2018;160:597–605. doi: 10.17236/sat00179. [DOI] [PubMed] [Google Scholar]
- 29.European Medicines Agency (EMA) European Medicines Agency [accessed February 2026]; Veterinary regulatory.https://medicines.health.europa.eu/veterinary/en n.d. [Google Scholar]
- 30.Animal and Plant Quarantine Agency (APQA) Gimcheon: APQA; [2-February-2026]. Korea veterinary medical products information system.https://medi.qia.go.kr/searchMedicine n.d. accessed. [Google Scholar]
- 31.Postma M, Sjölund M, Collineau L, Lösken S, Stärk KDC, et al. Assigning defined daily doses animal: a European multi-country experience for antimicrobial products authorized for usage in pigs. J Antimicrob Chemother. 2015;70:294–302. doi: 10.1093/jac/dku347. [DOI] [PubMed] [Google Scholar]
- 32.Hardefeldt LY, Browning GF, Thursky K, Gilkerson JR, Billman‐Jacobe H, et al. Antimicrobials used for surgical prophylaxis by equine veterinary practitioners in Australia. Equine Vet J. 2018;50:65–72. doi: 10.1111/evj.12709. [DOI] [PubMed] [Google Scholar]
- 33.Hardefeldt LY, Gilkerson JR, Billman‐Jacobe H, Stevenson MA, Thursky K, et al. Antimicrobial labelling in Australia: a threat to antimicrobial stewardship? Aust Veterinary J. 2018;96:151–154. doi: 10.1111/avj.12677. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
